BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 19919906)

  • 1. Keratinocyte and lymphocyte apoptosis: relation to disease outcome in systemic lupus erythematosus patients with and without cutaneous manifestations.
    Salem SA; Farouk HM; Mostafa AA; Hassan IM; Osman WM; Al-Shamy HA; Assaf NY
    Eur J Dermatol; 2010; 20(1):35-41. PubMed ID: 19919906
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Keratinocyte apoptosis and p53 expression in cutaneous lupus and dermatomyositis.
    Pablos JL; Santiago B; Galindo M; Carreira PE; Ballestin C; Gomez-Reino JJ
    J Pathol; 1999 May; 188(1):63-8. PubMed ID: 10398142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is disturbed clearance of apoptotic keratinocytes responsible for UVB-induced inflammatory skin lesions in systemic lupus erythematosus?
    Reefman E; de Jong MC; Kuiper H; Jonkman MF; Limburg PC; Kallenberg CG; Bijl M
    Arthritis Res Ther; 2006; 8(6):R156. PubMed ID: 17014704
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abnormal Fas/FasL and caspase-3-mediated apoptotic signaling pathways of T lymphocyte subset in patients with systemic lupus erythematosus.
    Xue C; Lan-Lan W; Bei C; Jie C; Wei-Hua F
    Cell Immunol; 2006 Feb; 239(2):121-8. PubMed ID: 16808908
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systemic disease in subacute cutaneous lupus erythematosus: a controlled comparison with systemic lupus erythematosus.
    Cohen MR; Crosby D
    J Rheumatol; 1994 Sep; 21(9):1665-9. PubMed ID: 7799346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Skin sensitivity to UVB irradiation in systemic lupus erythematosus is not related to the level of apoptosis induction in keratinocytes.
    Reefman E; Kuiper H; Jonkman MF; Limburg PC; Kallenberg CG; Bijl M
    Rheumatology (Oxford); 2006 May; 45(5):538-44. PubMed ID: 16352635
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lymphocyctes Tgammadelta in clinically normal skin and peripheral blood of patients with systemic lupus erythematosus and their correlation with disease activity.
    Robak E; Niewiadomska H; Robak T; Bartkowiak J; Błoński JZ; Woźniacka A; Pomorski L; Sysa-Jedrezejowska A
    Mediators Inflamm; 2001 Aug; 10(4):179-89. PubMed ID: 11577994
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased T-lymphocyte apoptosis in lupus correlates with disease activity and may be responsible for reduced T-cell frequency: a cross-sectional and longitudinal study.
    Dhir V; Singh AP; Aggarwal A; Naik S; Misra R
    Lupus; 2009 Aug; 18(9):785-91. PubMed ID: 19578102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum neopterin, tumor necrosis factor-alpha and soluble tumor necrosis factor receptor II (p75) levels and disease activity in Egyptian female patients with systemic lupus erythematosus.
    Mahmoud RA; El-Gendi HI; Ahmed HH
    Clin Biochem; 2005 Feb; 38(2):134-41. PubMed ID: 15642275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased apoptotic neutrophils and macrophages and impaired macrophage phagocytic clearance of apoptotic neutrophils in systemic lupus erythematosus.
    Ren Y; Tang J; Mok MY; Chan AW; Wu A; Lau CS
    Arthritis Rheum; 2003 Oct; 48(10):2888-97. PubMed ID: 14558095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Matrix metalloproteinases as mediators of tissue injury in different forms of cutaneous lupus erythematosus.
    Järvinen TM; Kanninen P; Jeskanen L; Koskenmies S; Panelius J; Hasan T; Ranki A; Saarialho-Kere U
    Br J Dermatol; 2007 Nov; 157(5):970-80. PubMed ID: 17854363
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Murine models of cutaneous involvement in lupus erythematosus.
    Ghoreishi M; Dutz JP
    Autoimmun Rev; 2009 May; 8(6):484-7. PubMed ID: 19239927
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced propensity of T lymphocytes in patients with systemic lupus erythematosus to apoptosis in the presence of tumour necrosis factor alpha.
    Habib HM; Taher TE; Isenberg DA; Mageed RA
    Scand J Rheumatol; 2009; 38(2):112-20. PubMed ID: 19110660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The study of Cutaneous Lupus Erythematosus Disease Area and Severity Index in Indian patients with systemic lupus erythematosus.
    Salphale P; Danda D; Chandrashekar L; Peter D; Jayaseeli N; George R
    Lupus; 2011 Dec; 20(14):1510-7. PubMed ID: 21997966
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histologic features of cutaneous lupus erythematosus.
    Baltaci M; Fritsch P
    Autoimmun Rev; 2009 May; 8(6):467-73. PubMed ID: 19162243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased apoptosis of peripheral blood lymphocytes and its association with interleukin-18 in patients with active untreated adult-onset Still's disease.
    Chen DY; Hsieh TY; Hsieh CW; Lin FJ; Lan JL
    Arthritis Rheum; 2007 Dec; 57(8):1530-8. PubMed ID: 18050226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High interleukin-10 production in first-degree relatives of patients with generalized but not cutaneous lupus erythematosus.
    van der Linden MW; Westendorp RG; Sturk A; Bergman W; Huizinga TW
    J Investig Med; 2000 Sep; 48(5):327-34. PubMed ID: 10979237
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Up-regulation of cellular FLICE-inhibitory protein in peripheral blood B lymphocytes in patients with systemic lupus erythematosus is associated with clinical characteristics.
    Tao J; Dong J; Li Y; Liu YQ; Yang J; Wu Y; Li L; Shen GX; Tan ZJ; Tu YT
    J Eur Acad Dermatol Venereol; 2009 Apr; 23(4):433-7. PubMed ID: 19335730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lymphocyte apoptosis and macrophage function: correlation with disease activity in systemic lupus erythematosus.
    Jin O; Sun LY; Zhou KX; Zhang XS; Feng XB; Mok MY; Lau CS
    Clin Rheumatol; 2005 Apr; 24(2):107-10. PubMed ID: 15818511
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The roles of complement 1q and anti-C1q autoantibodies in pathogenesis of lupus nephritis].
    Zhang FC; Zhou B; Dong Y
    Zhonghua Yi Xue Za Zhi; 2005 Apr; 85(14):955-9. PubMed ID: 16061001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.